Nov 18, 2009 0
NeurogesX To Hold Conference Call To Discuss FDA Approval Of Qutenza(TM) (capsaicin) 8% Patch For Treatment Of Postherpetic Neuralgia (PHN)
NeurogesX, Inc. (Nasdaq: NGSX) announces that it will hold a conference call at 8:30a.m.
| Independent review site since 2002 | : 45,639 product reviews |
Beta Footprint
Learn how we can make a difference...together |
|
![]() |
Earth 4 Energy
This great site shows you how to cut your power bills by generating & |
|
![]() |
Green DIY Energy
This is an amazing product that will save you money and help the |
|
![]() |
Home Made Energy
If you've ever wanted to stop spending money on your electricity |
|
![]() |
Magniwork
This site promises the secrets of generating free electricity |
|
![]() |
Power 4 Home
A practical, easy to follow, step by step guide to generating |
Nov 18, 2009 0
NeurogesX, Inc. (Nasdaq: NGSX) announces that it will hold a conference call at 8:30a.m.
Nov 18, 2009 0
NeurogesX, Inc.
Nov 18, 2009 0
Covidien (NYSE: COV) announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate ExalgoTM (hydromorphone HCl extended release) tablets with staff from the United States Food and Drug Administration (FDA). Mallinckrodt Inc.
Nov 16, 2009 0
Several weeks ago, the FDA announced its intent to change, by summer 2011, its policy regarding the post-harvest processing of raw Gulf Coast oysters harvested in the warmer months.
Nov 16, 2009 0
Title: FDA OKs Menstrual Drug Lysteda Category: Health News Created: 11/16/2009 11:45:00 AM Last Editorial Review: 11/16/2009 11:45:22 AM